Symbiotec Pharmalab’s subsidiary secures commercialization rights for its injectable products...
Mumbai, October 2: Symbiotec Pharmalab’s shares surged nearly 6% after its wholly owned subsidiary, Knovea Pharmaceuticals, secured an exclusive partnership with a leading unnamed pharma firm to commercialise and distribute...
